New CEO appointed for animal health company

New CEO appointed for animal health company

Qualified veterinarian and animal health executive joins Simcro as CEO

Hamilton, November 17 2014 - Dr Roger Wakelin has been appointed as the new CEO of animal health delivery systems company Simcro. From December 1, Dr Wakelin will assume responsibility for all of the day to day operations. Current CEO Will Rouse will assume the role of Executive Chairman, while continuing to be a director and significant shareholder.

Dr Wakelin’s experience has spanned both production and companion animals. He worked for more than a decade in production and companion animal veterinary practices in New Zealand, Ireland, UK and South Africa. He moved into the animal health pharmaceutical industry and held technical, market development, marketing and senior management positions with companies such as Pitman Moore, Bayer and more recently Merial USA. Rouse says that Simcro’s Board of Directors are pleased and excited about their latest appointment.

“Roger, together with our new independent director, Dr Jorge Solé, provide Simcro with a unique understanding of the animal health space and will be of significant importance as we strive to create world class innovations for the animal health industry. This is a significant milestone in the evolution of Simcro,” says Rouse.

Will Rouse has held the position of CEO at Simcro since 2007. In 2013, The Riverside Company acquired a controlling interest in Simcro.

Founded in 1993, Hamilton-based Simcro is a design and manufacturing company that specialises in providing innovative customised animal health delivery solutions to the animal health pharmaceutical industry. Simcro currently has a number of projects under development for the leading global animal health companies. The company currently exports over 90 percent of its products to more than 65 countries.

ENDS

© Scoop Media